Podcast
Aspirin—Not Really for Primary Prevention - Frankly Speaking EP 248Guest: Jill M. Terrien, PhD, ANP-BC
Music Credit: Richard Onorato
Join us to hear a discussion on the important changes the AHA/ACC and USPSTF have made to their positions on the use of aspirin for primary prevention of cardiovascular disease. The organizations note that while aspirin for primary prevention lowers the risk of a myocardial infarction, its harmful effects may outweigh its benefits. Learn the aspirin recommendations for your patients in their 40s, 50s, and 60s who are at higher risk for a cardiovascular event.
Episode Resources and Links:
- New: https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
- Old: https://www.aafp.org/afp/2016/1015/od1.html
- https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer
Already listened on another platform?
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 11/1/2021
Expiration Date: 11/1/2022
Topics
Learning Objectives
- Review the rationale for aspirin’s role in cardiovascular risk prevention
- Summarize new data discussing risks and benefits of aspirin for primary prevention
Faculty
Frank J. Domino, MD
Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA
Supporters and Partners
Supported by
Not Applicable
Education Partner
Not Applicable